Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
16 Total results for product and free and sample content found
27 Nov 2020
Infographic: COVID-19 delivers an 8% sales growth injection to Germany's supplements market in the first half of the year, accelerating a long-term expansion.
By Eileen Francis 27 Nov 2020
UNPA anticipates supplies of a ‘significant number’ of China-sourced supplement ingredients will be ‘critical’ by late April as Covid-19 disrupts shipments. During a recent webinar, UNPA CEO Loren Israelsen said he expects disruptions to continue until at least mid-year.
Topic Coronavirus Cosmetics Dietary Supplements Distribution
By Malcolm Spicer 29 Oct 2020
"One of the issues that COVID-19 has brought out is, how safe is the production of animal-based food products?" says Innova Market Insights North America executive Tom Vierhile at AHPA sports nutrition conference.
By Tom Gallen 21 Oct 2020
UK trial involving 5,000 participants "has the potential to give a definitive answer to the question of whether vitamin D offers protection against COVID-19," according to researchers.
By Tom Gallen 15 Jul 2020
Coronavirus pandemic drove up sales of vitamin C supplements and other immunity boosters in Italy in the opening three months of the year.
By David Ridley 15 Jul 2020
UK's NICE reviews whether Vitamin D can prevent or treat COVID-19, finds evidence wanting.
By Eileen Francis 15 Jul 2020
Assertions that no convincing evidence supports that probiotics available in the US treat symptoms of diarrhea, irritable bowel syndrome or allergies look at the category as a whole and not individual strains shown to help with specific conditions, say consumer health industry groups.
Topic Coronavirus Dietary Supplements Research & Development
By Malcolm Spicer 22 Jun 2020
FDA and FTC continue adding to total each has made during novel coronavirus pandemic. FTC's latest include peroxide gel and licorice as treatments; FDA’s emphasizes in warnings that three businesses' tests were not approved for OTC sales or for home use.
By David Ridley 14 May 2020
Australia looks at switching CBD as an OTC medicine, CBDepot becomes the first European firm with an EU Novel Food validation and the UK's Vitality CBD gets a boost from the global, coronavirus-driven wellness trend.
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: